Supramolecular Combination Cancer Therapy Based on Macrocyclic Supramolecular Materials

Супрамолекулярная комбинированная терапия рака на основе макроциклических супрамолекулярных материалов
Yilin Li, Yueyue Chen, Zhaoxiang Li, Yuteng Su
2022-11-11

gene chemotherapyhost–guest interactionmacrocyclic supramolecular materialsphotothermal chemotherapysupramolecular combination therapy
Supramolecular combination therapy adopts supramolecular materials to design intelligent drug delivery systems with different strategies for cancer treatments. Thereinto, macrocyclic supramolecular materials play a crucial role in encapsulating anticancer drugs to improve anticancer efficiency and decrease toxicity towards normal tissue by host-guest interaction. In general, chemotherapy is still common therapy for solid tumors in clinics. However, supramolecular combination therapy can overcome the limitations of the traditional single-drug chemotherapy in the laboratory findings. In this review, we summarized the combination chemotherapy, photothermal chemotherapy, and gene chemotherapy based on macrocyclic supramolecular materials. Finally, the application prospects in supramolecular combination therapy are discussed.
1
Macrocyclic supramolecular materials enable host–guest encapsulation of anticancer drugs, potentially improving efficacy while reducing toxicity to normal tissues.
2
Supramolecular combination therapy addresses limitations of conventional single-drug chemotherapy for solid tumors, based on laboratory findings.
3
The paper discusses future application prospects and challenges for macrocyclic supramolecular materials in supramolecular combination cancer therapy.
4
The review covers macrocycle-based combination chemotherapy, photothermal chemotherapy, and gene chemotherapy strategies.

macrocyclic supramolecular materials used in cancer drug-delivery systems

supramolecular combination cancer-therapy strategies, including combination chemotherapy, photothermal chemotherapy, and gene chemotherapy, with improved anticancer efficacy and reduced toxicity

Publication Details
Publication Date
2022-11-11
Journal
Publisher
ISSN
Cited by
16
Access Type
Author Information
Authors
Yilin Li
Yueyue Chen
Zhaoxiang Li
Yuteng Su
Explore further
Open the scid.ai AI chat with a ready-made request: it will find papers on a similar topic and help build a literature review.
Find similar papers in the chat →
Make a presentation
100%